Literature DB >> 4213959

Replication of measles virus: continued synthesis of nucleocapsid RNA and increased synthesis of mRNA in the presence of cycloheximide.

M P Kiley, F E Payne.   

Abstract

The effect of cycloheximide on virus specific RNA synthesis in Vero cells infected with either wild-strain (Edmonston) or subacute sclerosing panencephalitis strain measles virus was investigated. At 3 days postinfection, cells treated with cycloheximide (2.6 x 10(-4) M) and then exposed to [(3)H]uridine showed a marked increase in labeled virus-specific RNA. A major portion of this incremental labeled RNA was putative viral mRNA which sedimented at 16, 22, and 30S. Five distinct classes of polyribosomes, which were not evident in untreated cells, were found in cycloheximide-treated cells and each contained similar species of virus-specific RNA. Viral nucleocapsid RNA, 50 and 18S, was synthesized and encapsidated in the presence of cycloheximide. The latter observation is in apparent contrast to reports that cycloheximide inhibits replication of RNA of classical paramyxoviruses, and may indicate that mechanisms for replicating RNA of measles virus are different from those for replicating RNA of paramyxoviruses.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4213959      PMCID: PMC355580     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  POLYRIBOSOMES IN NORMAL AND POLIOVIRUS-INFECTED HELA CELLS AND THEIR RELATIONSHIP TO MESSENGER-RNA.

Authors:  S Penman; K Scherrer; Y Becker; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1963-05       Impact factor: 11.205

2.  Decreased reactivity of SSPE strains of measles virus with antibody.

Authors:  F E Payne; J V Baublis
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

3.  Inhibitor of vesicular stomatitis virus transcriptase in purified virions.

Authors:  J Perrault; D T Kingsbury
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

4.  Ribonucleic acid species of intracellular nucleocapsids and released virions of vesicular stomatitis virus.

Authors:  M P Kiley; R R Wagner
Journal:  J Virol       Date:  1972-08       Impact factor: 5.103

5.  Replication of measles virus: distinct species of short nucleocapsids in cytoplasmic extracts of infected cells.

Authors:  M P Kiley; R H Gray; F E Payne
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

6.  Effect of protein synthesis inhibitors on the replication of virus-induced RNA in Sendai virus-infected cells.

Authors:  V M Zaides; O G Nikolayeva; L M Selikova; A G Bukrinskaya
Journal:  Acta Virol       Date:  1973-07       Impact factor: 1.162

7.  The effect of cycloheximide on polyribosomes from hamster cells.

Authors:  C P Stanners
Journal:  Biochem Biophys Res Commun       Date:  1966-09-08       Impact factor: 3.575

8.  Effects of cycloheximide on polyribosome function in reticulocytes.

Authors:  W Godchaux; S D Adamson; E Herbert
Journal:  J Mol Biol       Date:  1967-07-14       Impact factor: 5.469

9.  Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins.

Authors:  P A Marx; A Portner; D W Kingsbury
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

10.  Mumps virus replication in chick embryo lung cells: properties of ribonucleic acids in virions and infected cells.

Authors:  J L East; D W Kingsbury
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

View more
  3 in total

1.  Dynamics of viral RNA synthesis during measles virus infection.

Authors:  Sébastien Plumet; W Paul Duprex; Denis Gerlier
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 2.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

3.  Isolation and characterization of temperature-sensitive mutants of measles virus.

Authors:  C M Bergholz; M P Kiley; F E Payne
Journal:  J Virol       Date:  1975-07       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.